克罗恩病肛瘘诊断与治疗的专家共识意见

2019-04-30 中国消化科相关专家小组(统称) 中华炎性肠病杂志.2019.3(2):105-110.

克罗恩病是一种病因及发病机制尚不清楚的慢性非特异性肠道炎性疾病,其中肛瘘是克罗恩病最常见的肛周病变。克罗恩病肛瘘的诊治需要多学科协作,最大限度地保护肛门功能。本共识意见旨在为我国克罗恩病肛瘘的临床诊治提供指导意见。

中文标题:

克罗恩病肛瘘诊断与治疗的专家共识意见

发布日期:

2019-04-30

简要介绍:

克罗恩病是一种病因及发病机制尚不清楚的慢性非特异性肠道炎性疾病,其中肛瘘是克罗恩病最常见的肛周病变。克罗恩病肛瘘的诊治需要多学科协作,最大限度地保护肛门功能。本共识意见旨在为我国克罗恩病肛瘘的临床诊治提供指导意见。 

拓展指南:克罗恩相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=克罗恩病肛瘘诊断与治疗的专家共识意见)] GetToolGuiderByIdResponse(projectId=1, id=110601c001ea8571, title=克罗恩病肛瘘诊断与治疗的专家共识意见, enTitle=, guiderFrom=中华炎性肠病杂志.2019.3(2):105-110., authorId=null, author=, summary=克罗恩病是一种病因及发病机制尚不清楚的慢性非特异性肠道炎性疾病,其中肛瘘是克罗恩病最常见的肛周病变。克罗恩病肛瘘的诊治需要多学科协作,最大限度地保护肛门功能。本共识意见旨在为我国克罗恩病肛瘘的临床诊治提供指导意见。 , cover=, journalId=null, articlesId=null, associationId=1327, associationName=中国消化科相关专家小组(统称), associationIntro=, copyright=0, guiderPublishedTime=Tue Apr 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>克罗恩病是一种病因及发病机制尚不清楚的慢性非特异性肠道炎性疾病,其中肛瘘是克罗恩病最常见的肛周病变。克罗恩病肛瘘的诊治需要多学科协作,最大限度地保护肛门功能。本共识意见旨在为我国克罗恩病肛瘘的临床诊治提供指导意见。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>克罗恩</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=5efe41c001e1859c" title="2019 多伦多共识:腔内克罗恩病管理临床实践指南" target=_blank>2019 多伦多共识:腔内克罗恩病管理临床实践指南</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=c9ae91c0016915ab" title="中国克罗恩病并发肠瘘诊治的专家共识意见" target=_blank>中国克罗恩病并发肠瘘诊治的专家共识意见</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=462c61c001688130" title="2019 SNFCP国家共识:克罗恩病肛门会阴病变的管理" target=_blank>2019 SNFCP国家共识:克罗恩病肛门会阴病变的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=7af621c00162837c" title="2018 多伦多共识:肛周瘘管性克罗恩病的医学管理指南" target=_blank>2018 多伦多共识:肛周瘘管性克罗恩病的医学管理指南</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=217bf1c00160e225" title="2018 多学科专家共识:克罗恩病抗纤维化狭窄治疗的标准化定义,诊断和治疗目标" target=_blank>2018 多学科专家共识:克罗恩病抗纤维化狭窄治疗的标准化定义,诊断和治疗目标</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%85%8B%E7%BD%97%E6%81%A9" target=_blank>有关克罗恩更多指南</a></ul>, tagList=[TagDto(tagId=91140, tagName=克罗恩病肛瘘)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7758, appHits=373, showAppHits=11, pcHits=3303, showPcHits=5282, likes=124, shares=20, comments=4, approvalStatus=1, publishedTime=Sun Jun 16 23:32:32 CST 2019, publishedTimeString=2019-04-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jun 16 23:32:32 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 05:28:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=克罗恩病肛瘘诊断与治疗的专家共识意见)])
克罗恩病肛瘘诊断与治疗的专家共识意见
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2116913, encodeId=825d211691388, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e33b6393082, createdName=ms3000000333116146, createdTime=Tue Feb 28 16:29:03 CST 2023, time=2023-02-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1202776, encodeId=c25c1202e76ce, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7aa2314876, createdName=122350edm30(暂无昵称), createdTime=Tue Mar 15 15:40:13 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202775, encodeId=83491202e75cc, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7aa2314876, createdName=122350edm30(暂无昵称), createdTime=Tue Mar 15 15:39:56 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367887, encodeId=6ba936e887f8, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Mon Jun 17 07:21:54 CST 2019, time=2019-06-17, status=1, ipAttribution=)]
    2023-02-28 ms3000000333116146 来自北京

    1

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2116913, encodeId=825d211691388, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e33b6393082, createdName=ms3000000333116146, createdTime=Tue Feb 28 16:29:03 CST 2023, time=2023-02-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1202776, encodeId=c25c1202e76ce, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7aa2314876, createdName=122350edm30(暂无昵称), createdTime=Tue Mar 15 15:40:13 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202775, encodeId=83491202e75cc, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7aa2314876, createdName=122350edm30(暂无昵称), createdTime=Tue Mar 15 15:39:56 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367887, encodeId=6ba936e887f8, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Mon Jun 17 07:21:54 CST 2019, time=2019-06-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2116913, encodeId=825d211691388, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e33b6393082, createdName=ms3000000333116146, createdTime=Tue Feb 28 16:29:03 CST 2023, time=2023-02-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1202776, encodeId=c25c1202e76ce, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7aa2314876, createdName=122350edm30(暂无昵称), createdTime=Tue Mar 15 15:40:13 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202775, encodeId=83491202e75cc, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7aa2314876, createdName=122350edm30(暂无昵称), createdTime=Tue Mar 15 15:39:56 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367887, encodeId=6ba936e887f8, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Mon Jun 17 07:21:54 CST 2019, time=2019-06-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2116913, encodeId=825d211691388, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e33b6393082, createdName=ms3000000333116146, createdTime=Tue Feb 28 16:29:03 CST 2023, time=2023-02-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1202776, encodeId=c25c1202e76ce, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7aa2314876, createdName=122350edm30(暂无昵称), createdTime=Tue Mar 15 15:40:13 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202775, encodeId=83491202e75cc, content=1, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7aa2314876, createdName=122350edm30(暂无昵称), createdTime=Tue Mar 15 15:39:56 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367887, encodeId=6ba936e887f8, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bbc11488193, createdName=thm112988, createdTime=Mon Jun 17 07:21:54 CST 2019, time=2019-06-17, status=1, ipAttribution=)]
    2019-06-17 thm112988

    0